Latest News
What does a Speedometer and the Costs of Drugs Have in Common?
What does a speedometer and the costs of drugs have in common, not much right? Wrong…it’s all about the patents. The Supreme Court is scheduled to hear arguments in the case of Cuozzo Speed Technologies, LLC v. Lee, which is challenging the new procedure – called inter partes review for patent challenges.
When someone challenges a patent in the court, patents are presumed to be valid and understood by their “plain and ordinary meaning” but with the new procedure a more broad interpretation is applied; to drug makers this is problem. Per Pharmaceutical Researchers and Manufacturers of America, it costs an average of $2.6 billion to develop a new drug; patent protection is required to justify that investment. Read the article here…
This posting is presented for informational purposes only and does not represent legal or financial guidance. Any opinions or interpretations presented are either those of the original author or, in the case of articles authored by the AMAC Foundation, are the opinions of AMAC Foundation staff, originally trained and accredited by the National Social Security Association (NSSA) and certified via the AMAC Foundation. Any links included in the article are valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the links’ validity. NSSA and the AMAC Foundation and its staff are not affiliated with or endorsed by the Social Security Administration or any other governmental entity. To submit a question, visit our website (https://amacfoundation.org/services/) or email us at ssadvisor@amacfoundation.org. Because we are a non-profit organization, there is no charge for these services.